Back to resultsRacial Disparities in Pneumococcal Vaccination in Managed Care
Primary Purpose
Pneumococcal Disease Prevention
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
phone call from nurses - informational only
Sponsored by
About this trial
This is an interventional educational/counseling/training trial for Pneumococcal Disease Prevention focused on measuring pneumococcal vaccination coverage with no disease or efficacy outcomes recorded
Eligibility Criteria
Inclusion Criteria: - recommended for pneumococcal vaccination according to age or medical comorbidity Exclusion Criteria: - already known to have received pneumococcal vaccine
Sites / Locations
- Kaiser Permanente
Outcomes
Primary Outcome Measures
pneumococcal vaccination coverage
Secondary Outcome Measures
Full Information
NCT ID
NCT00229762
First Posted
September 28, 2005
Last Updated
September 28, 2005
Sponsor
Centers for Disease Control and Prevention
Collaborators
Kaiser Permanente
1. Study Identification
Unique Protocol Identification Number
NCT00229762
Brief Title
Racial Disparities in Pneumococcal Vaccination in Managed Care
Official Title
Racial Disparities in Pneumococcal Vaccination in Managed Care: the Effects of Randomized Telephone Outreach
Study Type
Interventional
2. Study Status
Record Verification Date
September 2005
Overall Recruitment Status
Completed
Study Start Date
March 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
June 2005 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Centers for Disease Control and Prevention
Collaborators
Kaiser Permanente
4. Oversight
5. Study Description
Brief Summary
The goal of the study was to determine effectiveness of a telephone reminder to increase pneumococcal vaccination in a managed care population.
Detailed Description
Patients randomized to the intervention arm received a telephone call from managed care nurses asking about their pneumococcal vaccination status and whether they would like to be vaccinated. We compared six month follow-up of pneumococcal vaccination in electronic medical records for the intervention versus control group. We tested the percent vaccinated in each randomization arm using chi-square tests for proportions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pneumococcal Disease Prevention
Keywords
pneumococcal vaccination coverage with no disease or efficacy outcomes recorded
7. Study Design
Primary Purpose
Educational/Counseling/Training
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Single
Allocation
Randomized
Enrollment
7000 (false)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
phone call from nurses - informational only
Primary Outcome Measure Information:
Title
pneumococcal vaccination coverage
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
- recommended for pneumococcal vaccination according to age or medical comorbidity
Exclusion Criteria:
- already known to have received pneumococcal vaccine
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carla A Winston, PhD
Organizational Affiliation
Centers for Disease Control and Prevention
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaiser Permanente
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30333
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Racial Disparities in Pneumococcal Vaccination in Managed Care
We'll reach out to this number within 24 hrs